Skip to content

Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$ACTU

Actuate Therapeutics, Inc. Common stock

XNAS

$1.63
-3.55%-$0.060
RVOL peak today
Normal
Halted today
None today
Float
24.0M
Next earnings
Unscheduled
$1.63-3.55%$0.0600Prev $1.69LIVE Full chart Live alerts
No recent price bars, the chart lights up when ACTU starts printing.

Why is ACTU down today? It is at $1.63 (-3.55%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACTU spikes, and full due diligence on ACTU — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $ACTU alerts the moment volume spikes

Our scanner flagged $ACTU 14 times in the last 30 days. Create a free account to track $ACTU, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$1.63
Change today
-3.55%
Previous close
$1.69
52-week range
$0.900 – $9.22
Valuation & dividend
Market cap
$40M
Ownership & volume
Shares outstanding
24.0M
SEC · as of 2026-08-13 · 17d
Short interest
696K
▲ +55% vs prior · as of 2026-08-14
Short % of float
2.9%
Days to cover
3.6d
Avg daily volume
159K
Classification
Exchange
XNAS
Relative volumevs this time of day
5m
1.2x
15m
0.7x
1h
0.7x
1D
--

Get free ACTU + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $ACTU down today?

Here is the latest on ACTU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACTU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystACTUATE THERAPEUTICS, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 14, 2026 · 15 days ago
Why is $ACTU moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201

Insiders

3 open-market buys0 buys, 1 sells last 3 months (0/3 over 12 months)
Show 8 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Schmitt Daniel M
Officer
Sold (automatic/other)-121K
0.5% of company
sold 29%302K$122K
at $1.01
Aug 14, 26
Schmitt Daniel M
Officer
Other272K
1.1% of company
added 100%422Kn/aAug 14, 26
Schmitt Daniel M
Officer
Sold (automatic/other)-122K
0.5% of company
sold 45%150K$528K
at $4.33
Feb 13, 26
Schmitt Daniel M
Officer
Other272K
1.1% of company
n/a272Kn/aFeb 13, 26
Thomson Todd S
Director
Sold (automatic/other)-280K
1.2% of company
sold 11%2.35M$1.6M
at $5.80
Jan 5, 26
Fletcher Aaron G.L.
Director
Bought (open market)+71K
0.3% of company
added 0.7%10.20M$500K
at $7.00
Jun 27, 25
Kreis Leslie W.
Director
Bought (open market)+71K
0.3% of company
added 0.7%10.20M$500K
at $7.00
Jun 27, 25
Bios Equity Cof, Lp
Director
Bought (open market)+71K
0.3% of company
added 0.7%10.20M$500K
at $7.00
Jun 27, 25

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

$ACTU Sentiment

Bullish
Bearish68Bullish
📰 News: 3 bull · 0 bearToday: -3.6%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$ACTU Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Alert· 3d ago +7.8% vs EMA
ACTU 200EMA (5m) Trending · 100 bars · L4 · +7.78% above EMA · slope +2.19%
at $1.71
Alert· 3d ago
The Watcher SOLD $ACTU at $1.7100
at $1.71
Alert· 3d ago
The Watcher BOUGHT $ACTU at $1.7300
at $1.73
Alert· 3d ago -0.4% vs EMA
$ACTU crossed below 200 EMA (-0.38% vs EMA) at 2:57 PM ET
at $1.68
Alert· 3d ago -0.2% vs EMA
$ACTU near 200 EMA: -0.18% from 200 EMA at 2:56 PM ET
at $1.68
Alert· 3d ago
The Watcher SOLD $ACTU at $1.6800
at $1.68
Alert· 3d ago +2.8% vs EMA
$ACTU near 200 EMA: +2.78% from 200 EMA at 2:48 PM ET
at $1.73
Alert· 3d ago
The Watcher SOLD $ACTU at $1.8050
at $1.80
Alert· 3d ago
The Watcher BOUGHT $ACTU at $1.7400
at $1.74
Alert· 3d ago
The Watcher SOLD $ACTU at $1.7800
at $1.78
Alert· 3d ago
The Watcher BOUGHT $ACTU at $1.8100
at $1.81
Alert· 3d ago
The Watcher SOLD $ACTU at $1.8100
at $1.81
Alert· 3d ago +18.83%
$ACTU moved +18.83% (~15m high-low range 18.83%) (Level 5) at 2:32 PM ET
at $1.92
Alert· 3d ago 2258.2× RVOL
ACTU hit 2258.221x RVOL at 2:30 PM ET
at $1.78
Alert· 3d ago
The Watcher BOUGHT $ACTU at $1.8910
at $1.89
Alert· 3d ago 456.4× RVOL
ACTU hit 456.371x RVOL at 2:27 PM ET
at $1.88
Alert· 3d ago +11.2% vs EMA
ACTU 200EMA (1m) Trending · 68 bars · L3 · +11.17% above EMA · slope +1.00%
at $1.83
Alert· 3d ago +18.3% vs EMA
ACTU 200EMA (5m) Trending · 79 bars · L3 · +18.28% above EMA · slope +2.14%
at $1.83
Alert· 3d ago +5.48%
$ACTU moved +5.48% in 1 min (Level 1) at 2:24 PM ET
at $1.83
Alert· 3d ago 55.7× RVOL
ACTU hit 55.699x RVOL at 2:24 PM ET
at $1.83
News· SEC EDGAR· 15d ago
ACTUATE THERAPEUTICS, INC.: Q2 FY2026 results, three months to Jun 30, 2026
Alert· 38d ago -4.76%
$ACTU moved -4.76% in 1 min (Level 1) at 1:07 PM ET
at $1.27
Alert· 38d ago 24.6× RVOL
ACTU hit 24.603x RVOL at 1:07 PM ET
at $1.28
News· SEC EDGAR· 43d ago
ACTUATE THERAPEUTICS, INC. filed an 8-K: Delisting / Listing Deficiency
News· GlobeNewswire Inc.· 89d ago Bullish
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
News· SEC EDGAR· 99d ago
ACTUATE THERAPEUTICS, INC. filed an 8-K: Shareholder Vote
News· SEC EDGAR· 107d ago
ACTUATE THERAPEUTICS, INC. filed a Quarterly report (10-Q)
News· GlobeNewswire Inc.· 178d ago Bullish
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
News· Benzinga· 352d ago Neutral
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
News· GlobeNewswire Inc.· 455d ago Bullish
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

ACTU stock FAQ

Why is $ACTU down today?

Here is the latest on ACTU from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACTU today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the ACTU stock price today?

ACTU last traded at $1.63, down 3.55% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live ACTU alerts?

The ACTU Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACTU 14 times in the last 30 days.

What exchange is ACTU on?

ACTU (Actuate Therapeutics, Inc. Common stock) trades on XNAS, with a market cap of about $40M.

Is ACTU good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACTU for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.